Sirtuins Modulation: A Promising Strategy For HIV-Associated Neurocognitive Impairments Part 1

Abstract: 

HIV-Associated neurocognitive disorder (HAND) is one of the major concerns since it persists in 40% of this population. Nowadays, HAND neuropathogenesis is considered to be caused by the infected cells that cross the brain–blood barrier and produce viral proteins that can be secreted and internalized into neurons leading to the disruption of cellular processes. 

In recent years, studies have shown that viral proteins are closely related to memory.

First, viral proteins can stimulate the growth and development of brain neurons, enhance the connectivity and plasticity of neurons, and thus improve memory.

Second, viral proteins can activate neurons in the brain, stimulate more neurons to be excited, promote the connection and information transmission between neurons, and help strengthen memory and learning ability.

In addition, viral proteins can also affect the human immune system, promote the normal metabolism of the body, and help maintain body balance, thereby affecting people's mental state and improving people's memory.

But it should also be pointed out that people who are under high pressure for a long time are prone to decreased immunity. Therefore, reasonable control of stress and maintaining good living habits are also important factors in improving memory.

In summary, the impact of viral proteins on the human body is multifaceted, but overall, it has a promoting effect on human memory. In daily life, we should pay attention to maintaining good health, enhancing resistance, and making the role of viral proteins reach the best state. At the same time, we must also maintain a positive attitude, face life and work with an optimistic attitude, and believe that we can improve our memory and achieve better results. It can be seen that we need to improve memory, and Cistanche can significantly improve memory because Cistanche is a traditional Chinese medicine with many unique effects, one of which is to improve memory. The effect of Cistanche comes from the various active ingredients it contains, including tannic acid, polysaccharides, flavonoid glycosides, etc. These ingredients can promote brain health in many ways.

Click Know short-term Memory how to improve

The evidence points to viral proteins such as Tat as the causal agent for neuronal alteration and thus HAND. The hallmarks of Tat-induced neurodegeneration are endoplasmic reticulum stress and mitochondrial dysfunction. 

Sirtuins (SIRTs) are NAD+-dependent deacetylases involved in mitochondria biogenesis, unfolded protein response, and intrinsic apoptosis pathway. Tat interaction with these deacetylases causes inhibition of SIRT1 and SIRT3. Studies revealed that SIRT activation promotes neuroprotection in neurodegenerative diseases such as Alzheimer's and Parkinson's disease. 

Therefore, this review focuses on Tat-induced neurotoxicity mechanisms that involve SIRTs as key regulators and their modulation as a therapeutic strategy for tackling HAND and thereby improving the quality of life of people living with HIV.

Keywords: sirtuin; SIRT1; SIRT3; SIRT2; HIV; resveratrol; ER-stress; mitochondrial dysfunction; neurodegeneration; HAND.

1. Introduction

In 2020, the human immunodeficiency virus (HIV) infected more than 37 million people around the world, and 73% of this population was under antiretroviral therapy [1]. This combined antiretroviral treatment (cART) has expanded their life span. 

However, comorbidities have emerged, provoking changes in the central nervous system (CNS). Neuroimaging techniques have provided evidence of morphological changes in the brains of people living with HIV (PLWH). 

Additionally, reports showed the presence of HIV in cerebrospinal fluid and post-mortem brain tissues even when the viral load was undetectable in blood [2]. 

Collectively, these alterations are denominated as HIV-associated neurocognitive disorders (HAND) and are categorized depending on severity according to the Frascati criteria as asymptomatic neurocognitive impairment (ANI), mild neurocognitive disorder (MND), or HIV-associated dementia (HAD) [3]. The global prevalence of HAND was estimated at around 40%, with the milder form being the most common among the HAND patients [4,5]. 

Frascati criteria have been extensively utilized for identifying each level of HAND; they apply neuropsychological tests and exclude any comorbidity condition that could cause cognitive impairments. 

ANI and MND are diagnosed when the performance of a minimum of two cognitive domains is at least 1 SD below the mean, evaluating no fewer than five cognitive domains, which can include attention, language, executive and motor function, working memory, speed of information processing, and learning. Nevertheless, in ANI, the daily activities are not affected, while MND patients show mild impairments in everyday activities. 

Finally, people diagnosed with HAD have a performance of 2 SD below the mean in two cognitive domains and evident difficulty in the achievement of day-to-day activities [3,6]. 

HAND causes a spectrum of cognitive impairment, motor dysfunction, and behavioral and emotional disorders [7–14]. Being at risk for developing HAND depends on the CD4+ count, time of infection, plasma viral load, and history of AIDS-defining illness [15]. Nowadays, HAND is considered to be caused by either the neurotoxicity of cART the viral proteins secreted by infected cells, or a combination of both [2]. 

HIV cannot infect the neuron, but it can cross the BBB through infected monocytes that produce viral proteins that provoke neurotoxicity [16]. In animal models and cell lines, it has been observed that the transactivator of transcription (Tat) induces alterations in CNS [17–21]. 

A hallmark in Tat-induced neurodegeneration is an endoplasmic reticulum (ER) stress [22,23] and mitochondrial dysfunction, which is characterized by disruptions in mitophagy [18], mtDNA [20], fusion and fission [24], and energy metabolism [25,26]. SIRTs, NAD+-dependent deacetylases, are involved in the molecular mechanisms of these mitochondrial processes [27,28]. 

Furthermore, the data have revealed a cross-interaction between Tat and SIRTs, causing their inactivation [29–31]. In this review, we focus on the approaches that the viral protein Tat employs to induce neurotoxicity through disruption of SIRTs-regulated pathways. 

Conversely, we propose the use of SIRT modulators such as NAD+ precursors, and natural and synthetic compounds, as a possible therapeutic strategy, together with ART, to improve cognitive deficits in PLWH; hence, currently, there is no effective treatment to tackle this illness (Figure 1).

2. HAND and the Long-Term Exposure to ART

The prevalence of HAND, even in the era of ART, has directed attention towards antiretrovirals with higher CNS-penetration-effectiveness (CPE), expecting this classification would have tackled the problem [32]. 

Nonetheless, treatments with this characteristic proved to be associated with HAND, especially efavirenz [33–35]. Furthermore, other antiretrovirals with different CPE have been reported as neurotoxic agents [36–38]. 

The mechanisms that govern ART-induced neurotoxicity depend on the class of drug. Initially, the nucleoside analog reverse-transcriptase inhibitors (NRTIs) were found to cause mitochondrial aberrations by the depletion of mtDNA due to the analogy of the active site of the HIV reverse transcriptase and the DNA polymerase gamma (PolG) that causes inhibition of mtDNA replication [39], which can be related to disruption of mitochondrial biogenesis. Additionally, exposure to protease inhibitors such as lopinavir showed an increase in oxidative stress-mediated by high ROS levels in neural cells and activation of endogenous antioxidant response [38]. 

In the case of ritonavir, it was found that it induces endoplasmic reticulum (ER) stress and mitochondrial outer-membrane permeabilization (MOMP) [40]. Finally, the data suggesting ART-mediated cognitive performance improvement is still controversial [38,41,42]; hence, some studies did not find a beneficial association, while Siangphoe et al. [42] concluded in a meta-analysis that ART reduces the risk of developing neuronal disorders such as HAND. Nevertheless, the study did not include in the analysis the type of ART of each patient, which raises a question about whether any specific antiretroviral or a combination of them is causing any neurocognitive deficit. 

Additionally, the diagnosis of HAND was not performed by the same scale, resulting in possible variation at the moment of identification of these conditions and the sensibility of the cognitive test to detect ANI [42]. 

As discussed above, time living with HIV seems to contribute to the development of neurocognitive impairment, which seems to converge with the exposure of ART and its toxicity. Therefore, special consideration must be taken to adjuvant drugs for proper prevention or treatment against HAND, considering not only the side effects of ART but also the concomitant cell alterations induced by viral proteins, such as Tat.

3. Transactivator of Transcription Tat

Tat, a small regulatory protein, is encoded in the gene of the HIV genome by two separated exons that after alternative splicing, and the protein can be fully generated. The length depends upon the viral strain, which ranges from 86 to 101 amino acids. It is composed of N-terminal acidic or proline-rich, cysteine-rich, hydrophobic core; basic and glutamine-rich domains; and an RGD motif. 

That has residue variability, causing a range of activation and inhibitory results on host proteins and gene expression. Only the residue W11 and sequence 49RKKRRQRRR57 are well-conserved residues due to the essential function of secretion and uptake of Tat bystander cells [43].

Secretion and Internalization of Tat

Infected cells that penetrate the blood-brain barrier (BBB) can release viral protein as Tat in an unconventional manner because it lacks a signal peptide to transit across the Golgi apparatus or the endoplasmic reticulum [44]. 

Once Tat is recruited to the cell membrane, its basic domain, and residue W11 interact with phosphatidylinositol-4,5- bisphosphate (PI(4,5)P2) [45]. The subsequent mechanisms have not been completely elucidated. On the one hand, reports have shown that Tat can oligomerize and form pores in the plasma membrane. 

On the other side, binding to PI(4,5)P2 allows the insertion of residue W11 into the cell membrane; then, it is translocated to the extracellular matrix by an unclear process [44–46]. Finally, studies have reported exosomes contained Tat [44,47]; nevertheless, exosomal Tat seems to have lost its neurotoxicity property [19].

Extracellular Tat enters the cell by endocytosis. After internalization, Tat translocates into the cell cytoplasm. Conformational change takes place as a result of low pH, allowing exposure of W11 residue, which interacts with the endosomal membrane [48]. 

Additionally, the calcium coming from endolysosome-resident two-pore channels assists Tat regarding the escape of endolysosome [49]. Further, Ruiz et al. found a reduction of 70% in the uptake of Tat by bystander cells mediated by substitution in the basic domain (R57S), proving the pivotal relation of residue R57 in the cellular internalization of Tat [50]. 

Tang et al. attributed Tat-induced synaptic damage to its ability to penetrate cell membranes [19]. Indeed, a short sequence of Tat is being used as a cell-penetrating peptide for delivering drugs in other illnesses like cancer [51]. 

It seems that Tat uses different strategies to get inside and out of the cell, which makes it a significant target for the prevention of neuronal alterations. Therefore, we detailed the mechanisms involved in the following sections.

4. Tat and Mitochondria

Mitochondria are organelles involved in several cellular processes, including energy production in an oxidative phosphorylation manner, apoptosis signaling, calcium homeostasis [52], and cellular aging regulation [53]. 

Studies have focused on the role of mitochondria in neuronal disorders not only in Parkinson's disease (PD) or Alzheimer's disease (AD) [54] but also in HAND [55]. Sanna et al. [56] demonstrated the presence of mitochondrial dysfunction mediated by high HIV RNA load, which was determined by low TCA cycle and oxidative phosphorylation protein levels in brain regions of HIV patients [56]. 

It was observed that Tat remained near the mitochondria [57,58], suggesting cellular distribution is related to organelle alterations. Accordingly, other findings revealed that Tatexposed cells present mtDNA damage [20,59] and alteration in its methylation patterns [60], mitochondrial membrane potential reduction [23] changes in size and morphology of the organelle, fusion-fission triggering [24], increased mitochondrial ROS [61,62], mitophagy disruption [17,57], mitochondrial functions dysregulation [17,61] calcium homeostasis disturbance [61,63,64], and apoptosis activation [23,58,61,65,66].

4.1. Tat and Fusion-Fission Dynamics

Mitochondria is a highly dynamic organelle that undergoes fusion and fission to maintain functional processes. In neurons, energetic demand triggers mitochondria fusion/fission-mediated distribution to axons and dendrites. 

The fusion of the OMM is regulated by GTPases mitofusin 1 and 2 (MFN1, MFN2), while the fusion of the inner mitochondrial membrane (IMM) is controlled by optic atrophy protein 1 (OPA1). 

Meanwhile, mitochondrial division events are mediated by dynamin-related protein 1 (DRP1), a GTPase from the dynamin superfamily. It has been observed in Drp1 and Mnf2 knockout mice that cells were unable to properly distribute mitochondria [67]. 

Tat-Tg mice showed small fragmented mitochondria and Tat-exposed cortical neurons exhibited an increase in DRP1 and calcineurin, suggesting that Tat induces mitochondrial fragmentation by dysregulation of Ca2+ homeostasis, which triggers calcineurin mediated DRP1 activation [24].

4.2. Mitophagy Disruption

Mitochondria is the powerhouse of the cell, and therefore their maintenance is crucial for cellular physiology. Damaged mitochondria trigger quality control pathways to restore mitochondria network and energy metabolism. 

When the dysfunctional mitochondria persist, cells undergo mitophagy, which involves the degradation of aberrant organelles [68]. The phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1) is a crucial regulator of mitophagy. During basal conditions, PINK1 is translocated into the inner mitochondrial membrane and degraded. 

Nevertheless, under loss of mitochondrial membrane potential, PINK1 is accumulated in OMM, where it initiates mitophagosome formation. To label non-functional mitochondria, PINK1 autophosphorylates and recruits parkin to the mitochondria surface. 

Then, ubiquitination of proteins in OMM takes place by parkin E3 ligase activity, followed by mobilization of autophagy receptors such as sequestome 1 (SQSTM1) to enclose damaged mitochondria into the mitophagosome [68]. In mouse microglia, Tat increases the expression of PINK, indicating activation of mitophagy. 

In addition, data showed not only higher levels of mitophagy sensor proteins but their active translocation to mitochondria in Tat-exposed human primary neurons [57]. In both research groups, SQSTM1 was found to increase, suggesting mitophagy flux impairment, which was also confirmed by the accumulation of mitophagosomes observed by the fluorescence reporter system [57]. 

It is suggested that incomplete mitophagy might occur because the fusion of lysosomes to the mitophagosomes is blocked due to immature phagosomes formed or cells cannot balance degradation of them at the same rate they are formed [17]. It seems that further investigations are needed to clarify the cause of the obstruction of clearance of damaged mitochondria. 

The blockage of mitochondria quality control leads to the production of proinflammatory cytokines, contributing to neuroinflammation. However, gene silencing of pink1 causes prevention of HIV-Tat-induced mitophagy and thus accumulation of mitophagosomes, but it is unsuccessful in restoring ATP production rate [17]. 

In this regard, searching for the key regulator of mitophagy proteins that could be dysregulated is necessary since manipulation of mitophagy markers did not result in restoration of mitochondria functions, which in turn provoked neurodegeneration.

4.3. Tat-Induced Apoptosis

The reported data shows that Tat-exposed cells undergo extrinsic [65] and intrinsic apoptosis pathways [23]. In the first one, the signaling process starts in the cell membrane and is triggered by stimulation of death receptors, followed by activation of caspases to initiate cell death. 

The intrinsic apoptosis pathway is also referred to as the mitochondrial apoptotic pathway because MOMP is required to trigger caspase signaling that induces apoptosis [54]. 

Recently, most studies have acknowledged the significant role of the mitochondrial pathway in Tat-induced apoptosis and its crosstalk to ER stress and unfolded protein response (UPR) [23,69,70]. The cell, in the presence of apoptotic stimuli, translocates BCL-2-associated X protein (BAX) from the cytoplasm to the OMM, where it oligomerizes and interacts with BCL-2 antagonist/killer (BAK) acting as pores after binding with pro-apoptotic activators [71]. 

The BH3-only proteins such as BCL-2- interacting mediator of cell death (BIM), BH3-interacting domain death agonist (BID), and p53-upregulated modulator of apoptosis (PUMA) are pro-apoptotic members of the B cell lymphoma 2 (Blc-2) family that interact with BAK and BAX leading to the release of intermembrane space proteins such as cytochrome c and thus MOMP [71]. 

Consequently, these proteins initiate caspase activation leading to apoptosis. Note that MOMP is not only involved in the initiation of the apoptotic pathway, it is also related to the mtDNA release and proinflammatory signaling. The survival mechanism is regulated by the anti-apoptotic proteins from the same Bcl-2 family such as BCL-2 and B cell lymphoma extra-large (BCL-XL). 

These molecules bind to pro-apoptotic proteins, avoiding their interaction with BAX/BAK and the pore formation [71]. Hence, dysregulation of the BCL-2 proteins is an indication of the intrinsic apoptotic pathway as well as mitochondrial dysfunction. 

In Tat-exposed erythroleukemic cell line (K562) [58], human retinal microvascular endothelial cells [69], astroglioma cells [66], and human neuroblastoma cell [18], the mRNA levels of BCL-2 were lower compared to controls. Che et al. also found that the protein levels of BAX, BAK, and cytochrome c were increased by Tat in human retinal pigment epithelial cells (ARPE-19) [69]. 

According to these findings, Tat acts as a pro-apoptotic molecule, increasing MOMP by causing macropores formation in the OMM, which is also confirmed in reports of disruption of the mitochondrial membrane potential [23,58,70].

For more information:1950477648nn@gmail.com